IL6ST and breast carcinoma: Pre-clinical in vitro and in vivo studies have identified a number of candidate small molecule inhibitors that target the STAT3 signaling cascade, namely gp130, JAK and STAT3 itself, which inhibit growth and invasion of breast cancer models.